Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …
Neuralink, the neurotechnology firm led by entrepreneur Elon Musk, has reportedly achieved a significant milestone by successfully implanting its first …
Data is king in modern biopharmaceutical research, and ability to generate massive amounts of quality biomedical data represents a tremendous research …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.